Platelet-derived growth factor BB-induced p38 mitogen-activated protein kinase activation causes cell growth, but not

H Yamaguchi1, M Igarashi, A Hirata

  • 1Third Department of Internal Medicine, Yamagata University School of Medicine, Japan.

Endocrine Journal
|October 18, 2001
PubMed

Insights

Platelet-derived growth factor (PDGF)-BB activates p38 mitogen-activated protein (MAP) kinase, promoting vascular smooth muscle cell growth. This pathway may contribute to cardiovascular diseases like atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cell Biology
  • Signal Transduction

Background:

  • Vascular smooth muscle cells (VSMCs) play a critical role in cardiovascular health and disease.
  • Platelet-derived growth factor (PDGF)-BB is a key regulator of VSMC function.
  • The role of p38 mitogen-activated protein (MAP) kinase in PDGF-BB signaling in VSMCs requires further elucidation.

Purpose of the Study:

  • To investigate the regulation of p38 MAP kinase by PDGF-BB in rat VSMCs.
  • To determine the biological effects of PDGF-BB-induced p38 MAP kinase activation on VSMC proliferation and apoptosis.

Main Methods:

  • Primary rat VSMCs were isolated using the media explant technique.
  • Cells were stimulated with PDGF-BB and/or the p38 MAP kinase inhibitor SB-203580.
  • p38 MAP kinase phosphorylation was assessed by immunoblot analysis.
  • DNA synthesis and content were measured using [3H]-thymidine incorporation and Hoechst-33258 dye.
  • Apoptosis was evaluated using the TUNEL method.

Main Results:

  • PDGF-BB induced dose-dependent phosphorylation of p38 MAP kinase, which was inhibited by SB-203580.
  • PDGF-BB increased VSMC DNA synthesis and content, effects abolished by SB-203580.
  • PDGF-BB did not alter the total protein levels of p38 MAP kinase.
  • No significant apoptotic changes were observed in PDGF-BB-stimulated VSMCs, regardless of SB-203580 treatment.

Conclusions:

  • PDGF-BB activates p38 MAP kinase signaling in VSMCs, leading to increased cell proliferation.
  • This study provides a molecular mechanism linking p38 MAP kinase activation to VSMC growth.
  • The findings suggest a potential role for the PDGF-BB/p38 MAP kinase pathway in the pathogenesis of cardiovascular diseases such as atherosclerosis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...